Investment News
- Home
- About Us
- Newsroom
- Investment News
According to Yonhap News,
SEOUL, Dec. 25 (Yonhap) -- Major South Korean companies' spending on research and development (R&D) rose more than 11 percent on-year in 2019 despite a reduction in sales, a market tracker said Wednesday.
The combined R&D expenditures by the top 500 companies by sales stood at 39.3 trillion won (US$33.8 billion) in the first three quarters of the year, up 11.3 percent from a year earlier, according to CEO Score. The tally covers only 211 companies out of the total that have disclosed their R&D expenditures.
The surveyed companies posted 1,265.3 trillion won in combined revenue in the January-September period, down 0.8 percent from the same period a year ago.
Their total R&D spending took up 3.13 percent of sales, up 0.34 percentage point from a year earlier, CEO score said.
Naver Corp., the country's largest internet portal operator, ranked at the top among local companies in terms of R&D-to-sales ratio, with 25.96 percent, the data showed.
Major pharmaceutical firm Celltrion Inc., whose R&D-to-sales ratio was the highest in 2018, was relegated to second place with a ratio of 25.63 percent, the data showed.
Samsung Electronics Co., the world's largest smartphone and memory chipmaker, was the top R&D spender with 15.29 trillion won, but its R&D-to-sales ratio ranked 16th.
Copyrights Yonhap News. All Rights Reserved.
Reprint or redistribution without permission is prohibited.
khj@yna.co.kr
Source: Yonhap News (Dec. 25, 2019)